With this announcement, the Sri City plant becomes the fourth USFDA registered Healthium facility
Healthium Medtech has announced that the company has received USFDA (U.S. Food and Drug Administration) registration for its manufacturing facility in Sri City, Andhra Pradesh.
The company operates across eight integrated and scaled manufacturing facilities, several of which have global accreditations and registrations including with USFDA, CE, TGA, CDSCO and ISO. With this announcement, the Sri City plant becomes the fourth US FDA registered Healthium facility. It also has CDSCO, ISO 9001:2015 and EN ISO 13485: 2016 certifications.
Speaking on the recent development, Anish Bafna, Chief Executive Officer and Managing Director, Healthium Medtech said, “We are delighted to receive the USFDA registration for our Sri City facility in Andhra Pradesh, our 4th facility to receive it. This is testimony to our commitment to operational excellence and to our focus in delivering high quality, safe, value driven products aligned with our vision “Access to precision medtech for every patient, globally”
Healthium commenced its operations at the Sri City facility in calendar year 2012. The facility manufactures sutures, meshes with a production capacity of 1.20 million, as per the fiscal of 2021, and is located in a special economic zone (SEZ).